CDC23 and thyroid gland papillary carcinoma: Previous studies have demonstrated that LINC00514 accelerates cell proliferation and invasion in vitro and aggravates tumor growth by targeting the miR-204-3p/CDC23 axis in papillary thyroid cancer [19].